We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+21.34%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.42B
AUM Growth
+$56M
Cap. Flow
-$150M
Cap. Flow %
-10.6%
Top 10 Hldgs %
21.01%
Holding
400
New
86
Increased
74
Reduced
172
Closed
62

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$32.9M
2
DEN
Denbury Inc.
DEN
+$29.4M
3
ABG icon
Asbury Automotive
ABG
+$15.8M
4
FOXA icon
Fox Class A
FOXA
+$12.3M
5
STLA icon
Stellantis
STLA
+$11.7M

Sector Composition

Rank Sector Weight
1 Financials 18.93%
2 Energy 16.81%
3 Consumer Discretionary 16.27%
4 Industrials 13.92%
5 Healthcare 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBR icon
226
KBR
KBR
$4.67B
$804K 0.06%
+20,944
New +$668K
SCHW
227
Charles Schwab
SCHW
$181B
$799K 0.06%
12,253
+6,990
+133% +$424K
DLN icon
228
WisdomTree US LargeCap Dividend Fund
DLN
$6.25B
$770K 0.05%
13,428
-13,616
-50% -$749K
LMND icon
229
Lemonade
LMND
$4.76B
$755K 0.05%
8,104
+4,997
+161% +$645K
OMCL icon
230
Omnicell
OMCL
$1.89B
$750K 0.05%
+5,775
New +$741K
FDUS icon
231
Fidus Investment
FDUS
$751M
$742K 0.05%
47,727
-5,990
-11% -$85.4K
FMIVU
232
DELISTED
Forum Merger IV Corporation Unit
FMIVU
$742K 0.05%
+75,000
New +$746K
ASPCU
233
DELISTED
Alpha Capital Acquisition Co Unit
ASPCU
$739K 0.05%
+73,924
New +$753K
AEAC
234
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
$736K 0.05%
+75,904
New +$737K
GH icon
235
Guardant Health
GH
$19.3B
$730K 0.05%
4,785
-4,610
-49% -$697K
MIDD icon
236
Middleby
MIDD
$6.15B
$692K 0.05%
4,172
+810
+24% +$119K
VRAY
237
DELISTED
ViewRay, Inc.
VRAY
$692K 0.05%
+159,055
New +$772K
SCM icon
238
Stellus Capital Investment Corp
SCM
$204M
$689K 0.05%
54,246
-6,441
-11% -$73.8K
WHF icon
239
WhiteHorse Finance
WHF
$140M
$687K 0.05%
45,298
-5,879
-11% -$85K
TPTX
240
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$686K 0.05%
7,248
-1,418
-16% -$169K
AHCO icon
241
AdaptHealth
AHCO
$1.49B
$683K 0.05%
+18,583
New +$656K
BX icon
242
Blackstone
BX
$106B
$674K 0.05%
9,050
-1,730
-16% -$119K
MGNX icon
243
MacroGenics
MGNX
$254M
$672K 0.05%
+21,112
New +$513K
CPRI icon
244
Capri Holdings
CPRI
$1.82B
$666K 0.05%
+13,050
New +$615K
CSWC icon
245
Capital Southwest
CSWC
$1.46B
$664K 0.05%
29,970
-17,211
-36% -$351K
ARES icon
246
Ares Management
ARES
$28.8B
$660K 0.05%
11,775
-538
-4% -$27.1K
TRTN
247
DELISTED
Triton International Limited
TRTN
$652K 0.05%
11,853
+5,478
+86% +$293K
JLL icon
248
Jones Lang LaSalle
JLL
$15.5B
$642K 0.05%
+3,583
New +$584K
LEN icon
249
Lennar Class A
LEN
$20.5B
$641K 0.05%
6,543
-1,971
-23% -$166K
AAPL icon
250
Apple
AAPL
$4.95T
$632K 0.04%
5,175
-1,055
-17% -$135K

Similar funds

Advisory Research's Q1 2021 Portfolio in Review

As of Q1 2021, Advisory Research held 400 positions worth $1.42B, up 4.1% from $1.36B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Advisory Research withdrew a net $150M in Q1 2021, closing 62 positions and reducing 172 holdings. Its most notable exit was British American Tobacco, an estimated $35.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Advisory Research opened a new position in Devon Energy worth $34.9M.

  • Advisory Research's largest Q1 2021 buy was Devon Energy: 1,596,742 shares worth $34.9M.
  • Advisory Research added most to Cannae Holdings in Q1 2021, an estimated $8.24M increase.
  • Advisory Research's biggest Q1 2021 reduction was TSMC, cutting an estimated $35.1M.
  • Advisory Research fully exited British American Tobacco in Q1 2021, selling an estimated $35.1M.
  • Advisory Research's ten largest holdings make up 21% of its $1.42B portfolio in Q1 2021.
  • Advisory Research opened 86 new positions and closed 62 in Q1 2021.
  • Advisory Research's portfolio value rose 4.1% quarter-over-quarter to $1.42B.

Based on Advisory Research's 13F filing for Q1 2021, filed 12 May 2021.